Circulating Th17.1 Cells as Candidate for the Prediction of Therapeutic Response to Abatacept in Patients With Rheumatoid Arthritis: An Exploratory Research

PLoS ONE - United States
doi 10.1371/journal.pone.0215192
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study

PLoS ONE
Multidisciplinary
2016English

Effects of Abatacept on Monocytes in Patients With Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2010English

Experience With Subcutaneous Abatacept for Rheumatoid Arthritis: An Update for Clinicians

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2014English

P018 Anti-Carbamylated Protein Antibodies as a Clinical Response Predictor in Rheumatoid Arthritis Patients Treated With Abatacept

2019English

Increasing Levels of Circulating Th17 Cells and Interleukin-17 in Rheumatoid Arthritis Patients With an Inadequate Response to Anti-TNF-Α Therapy

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2011English

Exaggerated Circulating Th-1 Cytokine Response in Early Rheumatoid Arthritis Patients With Nodules

Cytokine
BiochemistryAllergyImmunologyHematologyMolecular Biology
2012English

Etanercept: Therapeutic Use in Patients With Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1999English

The Efficacy and Safety of Abatacept in Rheumatoid Arthritis

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2010English

Malignancies in the Rheumatoid Arthritis Abatacept Clinical Development Programme: An Epidemiological Assessment

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy